Investor profile
V-Bio Ventures has backed 7 European tech companies across 7 funding rounds between 2018 and 2022, joining rounds totalling €222M. Most active in Healthtech and Agritech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Precirix | Belgium | 1 | €80M |
| Camel-IDS | Belgium | 1 | €37M |
| AstriVax | Belgium | 1 | €30M |
| Sibylla Biotech | Italy | 1 | €23M |
| Coave Therapeutics | France |
| 1 |
| €21M |
| Agomab Therapeutics | Belgium | 1 | €21M |
| Animab | Belgium | 1 | €10M |
| €23M |
| 2022-10 |
| Coave Therapeutics | Series B | €21M | 2021-07 |
| Agomab Therapeutics | Series A | €21M | 2019-04 |
| Animab | Series A | €10M | 2022-11 |
